Sabry Hamza, based in Singapore, is currently a Director, Process development and Analytical Sciences at Tikva Allocell at Tikva Allocell Pte Ltd, bringing experience from previous roles at Tessa Therapeutics Ltd, Merck Sharp & Dohme and Genome Institute of Singapore. Sabry Hamza holds a 2000 - 2004 PhD in Comparative Pathology @ University of California, Davis. With a robust skill set that includes Genetics, Genomics, RNAi, miRNA, Gene Expression Profiling and more, Sabry Hamza contributes valuable insights to the industry. Sabry Hamza has 2 emails and 1 mobile phone number on RocketReach.